Ayala Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Return On Assets for the quarter ending December 31, 2023 was -339 %, a 126% decline year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Return On Assets for 2023 was -339 %, a 126% decline from 2022.
  • Ayala Pharmaceuticals, Inc. annual Return On Assets for 2022 was -150 %, a 319% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Return On Assets for 2021 was -35.8 %, a 40.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -339 -189 -126% Oct 1, 2023 Dec 31, 2023
Q3 2023 -277 -195 -239% Jul 1, 2023 Sep 30, 2023
Q2 2023 -216 -156 -263% Apr 1, 2023 Jun 30, 2023
Q1 2023 -167 -125 -298% Jan 1, 2023 Mar 31, 2023
Q4 2022 -150 -122 -427% Oct 1, 2022 Dec 31, 2022
Q3 2022 -81.7 -45.9 -128% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59.3 -19.9 -50.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42 +5.42 +11.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -28.5 +24.8 +46.5% Nov 1, 2021 Jan 31, 2022
Q3 2021 -35.8 +24.7 +40.8% Aug 1, 2021 Oct 31, 2021
Q2 2021 -39.5 +27 +40.6% May 1, 2021 Jul 31, 2021
Q1 2021 -47.4 +21.7 +31.4% Feb 1, 2021 Apr 30, 2021
Q4 2020 -53.2 +20.4 +27.7% Nov 1, 2020 Jan 31, 2021
Q3 2020 -60.5 -27.5 -83.3% Aug 1, 2020 Oct 31, 2020
Q2 2020 -66.4 -20.6 -45% May 1, 2020 Jul 31, 2020
Q1 2020 -69.2 -16.9 -32.4% Feb 1, 2020 Apr 30, 2020
Q4 2019 -73.7 -21.1 -40.2% Nov 1, 2019 Jan 31, 2020
Q3 2019 -33 +62.1 +65.3% Aug 1, 2019 Oct 31, 2019
Q2 2019 -45.8 +45.6 +49.9% May 1, 2019 Jul 31, 2019
Q1 2019 -52.3 +47.2 +47.5% Feb 1, 2019 Apr 30, 2019
Q4 2018 -52.5 +39.8 +43.1% Nov 1, 2018 Jan 31, 2019
Q3 2018 -95 -19.5 -25.7% Aug 1, 2018 Oct 31, 2018
Q2 2018 -91.5 -27 -41.8% May 1, 2018 Jul 31, 2018
Q1 2018 -99.5 -44.5 -80.8% Feb 1, 2018 Apr 30, 2018
Q4 2017 -92.3 -37.5 -68.4% Nov 1, 2017 Jan 31, 2018
Q3 2017 -75.6 -14 -22.6% Aug 1, 2017 Oct 31, 2017
Q2 2017 -64.5 -4.26 -7.07% May 1, 2017 Jul 31, 2017
Q1 2017 -55.1 +1 +1.78% Feb 1, 2017 Apr 30, 2017
Q4 2016 -54.8 +7.16 +11.6% Nov 1, 2016 Jan 31, 2017
Q3 2016 -61.6 -0.59 -0.97% Aug 1, 2016 Oct 31, 2016
Q2 2016 -60.2 +10.9 +15.3% May 1, 2016 Jul 31, 2016
Q1 2016 -56.1 +32.1 +36.4% Feb 1, 2016 Apr 30, 2016
Q4 2015 -62 +2 +3.13% Nov 1, 2015 Jan 31, 2016
Q3 2015 -61.1 +5.53 +8.31% Aug 1, 2015 Oct 31, 2015
Q2 2015 -71.2 +12 +14.5% May 1, 2015 Jul 31, 2015
Q1 2015 -88.2 -3.25 -3.83% Feb 1, 2015 Apr 30, 2015
Q4 2014 -64 +87.4 +57.7% Nov 1, 2014 Jan 31, 2015
Q3 2014 -66.6 +154 +69.8% Aug 1, 2014 Oct 31, 2014
Q2 2014 -83.2 +269 +76.4% May 1, 2014 Jul 31, 2014
Q1 2014 -84.9 +310 +78.5% Feb 1, 2014 Apr 30, 2014
Q4 2013 -151 +194 +56.2% Nov 1, 2013 Jan 31, 2014
Q3 2013 -220 +71.3 +24.5% Aug 1, 2013 Oct 31, 2013
Q2 2013 -352 -66.1 -23.1% May 1, 2013 Jul 31, 2013
Q1 2013 -395 -262 -198% Feb 1, 2013 Apr 30, 2013
Q4 2012 -346 Nov 1, 2012 Jan 31, 2013
Q3 2012 -291 Aug 1, 2012 Oct 31, 2012
Q2 2012 -286 May 1, 2012 Jul 31, 2012
Q1 2012 -133 Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.